Li Wang is the Senior Director of Health Economics and Outcomes Research (HEOR) at Regeneron, bringing extensive experience in epidemiology, outcomes research, and disease management. With a proven track record in leading successful companies for over a decade, Li has also served as the Director of Real World Evidence at Pfizer and held various leadership roles at STATinMED and UT Southwestern Medical Center. An accomplished speaker, Li has delivered over 300 presentations and publications spanning numerous therapeutic areas, including cancer and cardiovascular disease. Li earned a Ph.D. in Physiology from East China Normal University and holds an MBA from The University of Texas at Austin.
This person is not in the org chart
This person is not in any teams
This person is not in any offices